Quality in Endoscopy: IBD & Small Bowel Disease

Programme

Thursday, November 14, 2013
16.00 - 19.00
  • Registration
Friday, November 15, 2013
08.15
  • Official opening
  • Klaus Mönkemüller, Rami Eliakim
SESSION 1: OBSCURE GASTROINTESTINAL (GI) BLEEDING
Chairs: Rami Eliakim, Klaus Mönkemüller
08.30
  • Definition and classification of obscure GI bleeding
  • Ian Gralnek
08.50
  • THE GREAT DEBATE 1:
    Approach for OGIB
  • - Capsule endoscopy first Marco Pennazio
  • - Deep enteroscopy first Klaus Mönkemüller
  • - When to x-ray? Peter Lakatos
  • Discussion leader Ian Gralnek
09.30
  • Case presentations and discussion with audience participation
10.10
  • Coffee break and poster presentation
Session 2: Celiac disease
Chairs: Marco Penazzio, Michael Vieth
10.40
  • How to best diagnose celiac disease?
  • Giovanni Cammarota
11.05
  • Refractory celiac disease
  • Chris Mulder
11.30
  • Case presentations and discussion with audience participation
Session 3: Small bowel polyps and tumors
Chairs: Ian Gralnek, Chris Mulder
11.50
  • Endoscopic and radiologic methods to screen for polyps and tumors
  • Peter Lakatos
12.15
  • Endoscopic therapy for small bowel polyps and tumors
  • Helmut Neumann
12.40
  • Case presentations and discussion with audience participation
13.00
  • Lunch and poster presentation
Session 4: Inflammatory bowel disease of the small intestine
Chairs: Charlie Lees, Walter Reinisch
14.00
  • Endoscopic spectrum of IBD of the small bowel: how to differentiate from other ulcerative disorders?
  • James East
14.25
  • Is biopsy essential for the diagnosis of inflammatory bowel disease only affecting the small bowel?
  • Michael Vieth
14.45
  • Endoscopic diagnosis and treatment of small bowel strictures
  • Klaus Mönkemüller
15.10
  • Case presentations and discussion with audience participation
15.35
  • Coffee break and poster presentation
Session 5: Controversies  and future direction for Crohn’s disease
Chairs: Raf Bisschops, Szolt Tulassay
16.00
  • THE GREAT DEBATE 2:
    Upper GI endoscopy in diagnostic work-up of Crohn’s disease: Just for kids?
  • YES: should be only for children Walter Reinisch
  • NO: should be for everyone Rami Eliakim
  • Discussion leader Charlie Lees
16.40
  • How to improve the diagnosis of small bowel Crohn’s:
  • A) Radiological and ultrasound methods (MRE, CTE, US) Ivan Jovanovic
  • B) Capsule endoscopy: How to improve capsule sensitivity,
        specificity and diagnostic yield?     Rami Eliakim
  • C) Deep enteroscopy Peter Lakatos
17.30
  • Case presentations and discussion with audience participation
18.00
  • Meet 'n greet
Saturday, November 16, 2013
Session 6: Inflammatory bowel disease of the colon
Chairs: Matt Rutter, Szolt Tulassay
08.15
  • THE GREAT DEBATE 3:
    Endoscopic scoring systems for INFLAMMATORY BOWEL DISEASE – they should be used routinely in clinical practice!
  • PRO Helmut Neumann
  • CON Raf Bisschops
  • Discussion leader Evelien Dekker
09.00
  • The ideal scoring system for UC
  • James East
09.25
  • Video training session “Train your eye to score colonic IBD”
  • Philippe Marteau
  • Discussion leaders Evelien Dekker
    Charlie Lees
10.30
  • Coffee break and poster presentation
Session 7: Dysplasia and IBD
Chairs: Evelien Dekker, James East
11.00
  • THE GREAT DEBATE 4:
    The diagnosis and surveillance of ulcerative colitis should be performed with advanced imaging techniques
  • PRO Matt Rutter
  • CON Ivan Jovanovic
  • Discussion leader Helmut Neumann
11.50
  • THE GREAT DEBATE 5:  
    DALM vs. ALM: Of importance for decision-making in endoscopic or surgical therapy?
  • PRO Karel Geboes
  • CON Michael Vieth
  • Discussion leader Raf Bisschops
12.30
  • Case presentations and discussion with audience participation
13.15
  • Lunch and poster presentation
Session 8: New paradigms in IBD
Chairs: Rami Eliakim, Ivan Jovanovic
14.15
  • Conditions mimicking IBD
  • Chris Mulder
14.40
  • Biomarkers to evaluate established IBD: are they good enough to help the clinician?
  • Zsolt Tulassay
15.00
  • THE GREAT DEBATE 6:
    Mucosal healing as a target of therapy for IBD
  • PRO Charlie Lees
  • CON Walter Reinisch
  • Discussion leader Matt Rutter
16.00
  • Case presentations and discussion with audience participation
16.30
  • Closing words Evelien Dekker
    Charlie Lees